BMJ Open Respiratory Research is an open access peer-reviewed journal dedicated to publishing respiratory and critical care medicine research. The journal aims to provide rapid publication of research across a range of medical disciplines and therapeutic areas in respiratory medicine, through a continuous publication model. All submissions are subject to external peer review.
BMJ Open Respiratory Research adheres to the highest standards concerning its editorial policies on publication ethics and scientific misconduct. The journal follows guidance produced by bodies that include the Committee on Publication Ethics (COPE), the World Association of Medical Editors (WAME), the Council of Science Editors and the International Committee of Medical Journal Editors (ICMJE). To view all BMJ Journal policies please refer to the BMJ Author Hub policies page, including information about our Editors’ roles and responsibilities.
Authors are required to submit a statement that their study obtained ethics approval (or a statement that it was not required and why) and that participants gave informed consent. Our Editors will consider whether the work is morally acceptable as determined by the World Medical Association’s Declaration of Helsinki. In addition to this, in line with General Medical Council guidelines, an article that contains personal medical information about an identifiable living individual requires patients explicit consent (in the format of a signed BMJ patient consent form) before we will publish it. Please find further details on BMJ research ethics policies (human participants and animals) and consent for publication; including a link to the downloadable consent form.
To make the best decision on how to deal with a manuscript BMJ Open Respiratory Research needs to know about any competing interests authors may have; this includes any commercial, financial or non financial associations that may be relevant to the submitted article. Authors must download and complete a copy of the ICMJE Conflict of Interest disclosure form. In addition to this BMJ Open Respiratory Research ensures that all advertising and sponsorship associated with the journal does not influence editorial decisions, is immediately distinguishable from editorial content and meets all other BMJ guidelines. Please find more information about competing interests and a link to the form.
BMJ Open Respiratory Research will not consider for publication any study partly or wholly funded by the tobacco industry, as explained here.
We take seriously all possible misconduct. If an Editor, author or reader has concerns that a submitted article describes something that might be considered to constitute misconduct in research, publication or professional behaviour they should forward their concerns to the journal. The publisher will deal with allegations appropriately following ICMJE and COPE guidelines. Corrections and retractions are considered where an article has already been published; corrections, expressions of concern or a retraction notices will be published as soon as possible in line with the BMJ correction and retraction policy
Copyright and authors’ rights
As an open access journal, BMJ Open Respiratory Research adheres to the Budapest Open Access Initiative definition of open access. Articles are published under an exclusive licence or non-exclusive licence for UK Crown employees or where BMJ has agreed CC BY applies. For US Federal Government officers or employees acting as part of their official duties, the terms are as stated in accordance with our licence terms. Authors or their employers retain copyright. Such open access articles can be reused under the terms of the relevant Creative Commons licence to facilitate reuse of the content. please refer to the BMJ Open Respiratory Research Author Licence. More information on copyright and authors’ rights.
When publishing in BMJ Open Respiratory Research, authors choose between two licence types – CC-BY-NC and CC-BY (Creative Commons open access licences require payment of an article processing charge). As an author you may wish to post your article in an institutional or subject repository, or on a scientific social sharing network. You may also link your published article to your preprint (if applicable). What you can do with your article, without seeking permission, depends on the licence you have chosen and the version of your article. Please refer to the BMJ author self archiving and permissions policies page for more information.
Preprints foster openness, accessibility and collaboration by allowing authors to make their findings immediately available to the research community and receive feedback on an article before it is submitted to a journal for formal publication.
BMJ fully supports and encourages the archiving of preprints in any recognised, not-for-profit server such as medRxiv. BMJ does not consider the posting of an article in a dedicated preprint repository to be prior publication.
Preprints are reports of work that have not been peer-reviewed; preprints should therefore not be used to guide clinical practice, health-related behaviour or health policy. For more information, please refer to our Preprint policy page.
Tobacco industry funded work
BMJ Open Respiratory Research will not consider for publication papers reporting work funded, in whole or in part, by a tobacco company or tobacco industry organization. Nor will the journal consider papers by authors who accept tobacco industry funding, including funding for research costs, for all or part of any author’s salary, or other forms of personal remuneration.
For further information, please read this editorial giving the reasoning behind the journal’s policy. Failure to declare competing interests at submission, or when an article is commissioned, can result in immediate rejection of the paper. If a competing interest comes to light after publication, BMJ Open Respiratory Research will issue a formal correction to or retraction of the whole paper, as appropriate.
Provenance and peer review
BMJ Open Respiratory Research submissions are predominantly unsolicited. All articles submitted to BMJ Open Respiratory Research are subject to peer review. The journal operates single blind peer review whereby the names of the reviewers are hidden from the author; usually two external reviewer reports are obtained before an Original research or Review article is accepted for publication. Articles authored by a member of a journal’s editorial team are independently peer reviewed; an editor will have no input or influence on the peer review process or publication decision for their own article.
BMJ requests that all reviewers adhere to a set of basic principles and standards during the peer review process; these are based on the COPE Ethical Guidelines for Peer Reviewers. Please refer to our peer review terms and conditions policy page.
Reviewers are now able to share their activity by connecting their review to their ORCID account. As BMJ Open Respiratory Research is a single-blind peer-reviewed journal, only the journal title will be uploaded into the reviewer’s ORCID record and the date the record was uploaded; there is no identification of the article’s title or authors. Records are uploaded once a final decision or revision has been made on the article. Please find more information about ORCID and BMJ’s policy on our Author Hub.
BMJ is committed to transparency. Every article we publish includes a description of its provenance (commissioned or not commissioned) and whether it was internally or externally peer reviewed.
Plagiarism is the appropriation of the language, ideas or thoughts of another without crediting their true source and representation of them as one’s own original work. BMJ is a member of CrossCheck by CrossRef and iThenticate. iThenticate is a plagiarism screening service that verifies the originality of content submitted before publication. BMJ runs manuscripts through iThenticate during the peer review process. Authors, researchers and freelancers can also use iThenticate to screen their work before submission by visiting www.ithenticate.com.
Reader responses, questions and comments to published content is welcomed by BMJ Open Respiratory Research; these should be submitted electronically via the journals website. Please find further details on how to publish a response and the terms and requirements.
Article processing charges
BMJ Open Respiratory Research is an open access journal and levies an Article Processing Charge (APC) of 1,700 GBP (exclusive of VAT for UK and EU authors). The charge for publishing a study protocol is 1,000 GBP. There are no submission, colour or page charges.
Please see our Author Hub for detailed information on discounts and waivers. Applications for waivers or discounts should be made during initial submission and not after an article has been accepted. Editors are not involved in this process and the ability to pay has no bearing on editorial decisions. Payment will not be required unless your article is accepted. Accepted articles will not be published until payment has been received. BMJ does not refund APCs once paid.
Members of the British Thoracic Society, the British Sleep Society and the British Association of Lung Research are eligible for a 25% discount on the APC. Members of the Association of Respiratory Nurse Specialists may claim a 35% discount. Please inform the Editorial Office once your paper is accepted if you wish to claim the discount and you will receive a discount code (BMJ reserves the right contact the relevant society office to verify you are a paid-up member). A 25% reviewer discount is available for corresponding authors who have reviewed for BMJ Open Respiratory Research within the previous 12 months. These discounts cannot be combined.
For more information on open access, funder compliance, discounts and waivers please refer to the BMJ Author Hub open access page.
BMJ has a facility for transferring manuscripts between its respiratory journals. Authors submitting to Thorax can choose BMJ Open Respiratory Research as an alternate journal if their paper is rejected.
Once authors agree for their manuscript to be transferred to another BMJ journal, all versions of the manuscript, any supplementary files and peer review comments will automatically be transferred on the author’s behalf. Please note that there is no guarantee of acceptance. Contact the editorial team for more information or assistance.
BMJ Open Respiratory Research adheres to BMJ’s Tier 2 data policy. We strongly encourage that data generated by your research that supports your article be made available as soon as possible, wherever legally and ethically possible. We also require data from clinical trials to be made available upon reasonable request. To adhere to ICMJE guidelines, we require that a data sharing plan must be included with trial registration for clinical trials that begin enrolling participants on or after 1st January 2019.
Changes to the plan must be noted in the Data Availability Statement and updated in the registry record. All research articles must contain a Data Availability Statement. For more information and FAQs, please see BMJ’s full Data Sharing Policy page.
BMJ has long supported the use of ORCID by integrating ORCID into our submission systems. BMJ Open Respiratory Research mandates ORCID iDs for all submitting authors; this is published on the final article to promote discoverability and credit. Co-authors and reviewers are strongly encouraged to also connect their ScholarOne accounts to ORCID.
We are also working with ORCID to recognise the importance of the reviewer community. Reviewers are able to share their activity by connecting their review to their ORCID account to gain recognition for their contributions.
As BMJ Open Respiratory Research is a single-blind peer-reviewed journal, only the journal title will be uploaded into the reviewer’s ORCID record and the date the record was uploaded; there is no identification of the article’s title or authors. Records are uploaded once a final decision or revision has been made on the article. Please find more information about BMJ’s ORCID policy on our Author Hub.
Reporting patient and public involvement in research
BMJ encourages active patient and public involvement in clinical research as part of its patient and public partnership strategy. To support co-production of research we request that authors provide a Patient and Public Involvement statement in the methods section of their papers, under the subheading ‘Patient and public involvement’.
We appreciate that patient and public involvement is relatively new and may not be feasible or appropriate for all papers. We therefore continue to consider papers where patients were not involved.
The Patient and Public Involvement statement should provide a brief response to the following questions, tailored as appropriate for the study design reported (please find example statements here):
- At what stage in the research process were patients/the public first involved in the research and how?
- How were the research question(s) and outcome measures developed and informed by their priorities, experience, and preferences?
- How were patients/the public involved in the design of this study?
- How were they involved in the recruitment to and conduct of the study?
- Were they asked to assess the burden of the intervention and time required to participate in the research?
- How were (or will) they be involved in your plans to disseminate the study results to participants and relevant wider patient communities (e.g. by choosing what information/results to share, when, and in what format)?
If patients were not involved please state this.
In addition to considering the points above we advise authors to look at guidance for best reporting of patient and public involvement as set out in the GRIPP2 reporting checklist.
If the Patient and Public Involvement statement is missing in the submitted manuscript we will request that authors provide it.
Please review the below article type specifications including the required article lengths, illustrations, table limits and reference counts. The word count excludes the title page, abstract, tables, acknowledgements, contributions and references. Manuscripts should be as succinct as possible.
For further support when making your submission please refer to the resources available on the BMJ Author Hub. Here you will find information on writing and formatting your research through to the peer review process and promoting your paper. We encourage authors to ensure that research articles are written in accordance with the relevant research reporting guideline.
Original research should follow the basic structure of Abstract, Key Messages, Introduction, Methods, Results, Discussion, References, and tables and figures as appropriate.
Following the lead of The BMJ and its patient partnership strategy, BMJ Open Respiratory Research is encouraging active patient involvement in setting the research agenda. As such, we require authors of Research Articles to add a Patient and Public Involvement statement in the Methods section. More details can be found under the “Reporting patient and public involvement in research” section above.
Word count: up to 4,000
Abstract: up to 300
Tables/illustrations: up to 5
References: up to 100
Authors should also complete a short ‘Key Messages’ section after the abstract indicating the significance of this study by addressing each of the below headings with 1 sentence:
- What is the key question?
- What is the bottom line?
- Why read on?
Protocols should report planned or ongoing studies. If data collection is complete, we will not consider the manuscript. BMJ Open Respiratory Research will consider for publication protocols for any study design, including observational studies and systematic reviews. More information on protocols can be found on the BMJ Author Hub.
BMJ Open Respiratory Research will not consider protocols for systematic reviews.
Following the lead of The BMJ and its patient partnership strategy, BMJ Open Respiratory Research is encouraging active patient involvement in setting the research agenda. As such, we require authors of Research Articles to add a Patient and Public Involvement statement in the Methods section. Please see more details above.
Protocols should follow the following structure:
Title: This should include the specific study type, e.g. randomised controlled trial.
Abstract: This should be structured with the following sections. Introduction; Methods and analysis; Ethics and dissemination. Registration details should be included as a final section, if appropriate.
Introduction: Explain the rationale for the study and what evidence gap it may fill. Appropriate previous literature should be referenced, including relevant systematic reviews.
Methods and Analysis: Provide a full description of the study design, including the following. How the sample will be selected; interventions to be measured; the sample size calculation (drawing on previous literature) with an estimate of how many participants will be needed for the primary outcome to be statistically, clinically and/or politically significant; what outcomes will be measured, when and how; a data analysis plan.
Ethics and Dissemination: Ethical and safety considerations and any dissemination plan (publications, data deposition and curation) should be covered here.
References: State any references used.
Authors’ Contributions: State how each author was involved in writing the protocol.
Funding Statement: Preferably worded as follows. Either: ‘This work was supported by [name of funder] grant number [xxx]’ or ‘This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors’.
Competing Interests Statement: State any competing interests.
Perspective articles provide a forum for authors to discuss ideas and research from a personal viewpoint. Perspective pieces may focus on current advances and future directions in the field of respiratory and sleep medicine and may include original data as well as personal opinion.
Word count: up to 2,500
Abstract: unstructured, up to 250
Tables/illustrations: up to 5
State of the art review
State-of-the-art reviews will address any aspect of respiratory or critical care medicine. Some review articles may be commissioned but unsolicited submissions are welcomed.
Word count: up to 3,000
Abstract: up to 200
Tables/illustrations: up to 5
References: up to 100
The BMJ Publishing Group journals are willing to consider publishing supplements to regular issues. Supplement proposals may be made at the request of:
- The journal editor, an editorial board member or a learned society may wish to organise a meeting, sponsorship may be sought and the proceedings published as a supplement.
- The journal editor, editorial board member or learned society may wish to commission a supplement on a particular theme or topic. Again, sponsorship may be sought.
- The BMJPG itself may have proposals for supplements where sponsorship may be necessary.
- A sponsoring organisation, often a pharmaceutical company or a charitable foundation, that wishes to arrange a meeting, the proceedings of which will be published as a supplement.
In all cases, it is vital that the journal’s integrity, independence and academic reputation is not compromised in any way.
For further information on criteria that must be fulfilled, download the supplements guidelines.
When contacting us regarding a potential supplement, please include as much of the information below as possible.
- Journal in which you would like the supplement published
- Title of supplement and/or meeting on which it is based
- Date of meeting on which it is based
- Proposed table of contents with provisional article titles and proposed authors
- An indication of whether authors have agreed to participate
- Sponsor information including any relevant deadlines
- An indication of the expected length of each paper Guest Editor proposals if appropriate